Company intelligence / Profile preview

Enigma Coding

Ownership: Private
Development stage: Other

Overview

Enigma Life Sciences provides technology scouting, valuation, competitive strategy analysis, and business development services to identify emerging technologies and companies in life sciences. It specializes in early-stage opportunities that are often under the radar for larger firms or investors. Founded by Mark Veugelers (PhD, MBA), it leverages extensive databases and deep expertise to support clients’ strategic growth decisions.

Industry: Consulting

Beyond the preview

Go deeper on Enigma Coding.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Enigma Coding.

Explore the full profile